Voisin Consulting Life Sciences presentation icon
Presentation

A Nonclinical Perspective on the Cell, Gene & Immunotherapy Need-to-Know Characteristics

Post thumbnail A Nonclinical Perspective on the Cell, Gene & Immunotherapy Need-to-Know Characteristics

After a brief look at the current European Guidelines for Advanced Therapy Medicinal Products (ATMPs), this presentation will go through the nonclinical development plan for ATMPs and how to ease its translation to the clinical setting, focusing on the nonclinical considerations and approaches.  Because ATMPs products have specific clinical target(s) and that any manufacturing process change could easily affect their intrinsic properties, the optimal nonclinical development plan should consists of an integrated approach involving CMC / NC and Clinical expertise and use of Target Product Profile, which, if they are critical for any pharmaceutical product, appear even more crucial for ATMPs development.

Voisin Consulting Life Sciences download icon

Download the full presentation now

Fill in the form to download the content
Yes, I would like to receive communications regarding VCLS services and events


Sample of the presentation

presentation by

Cécile Rousseau
Cécile F. Rousseau, PhD
Director, Nonclinical
With 10+ years in nonclinical and translational research and histotechnology, Dr. Cécile F. Rousseau has considerable expertise in medical devices,…
View profile